Survival and proliferation of prostate cancer cells depend critically on signaling through the androgen receptor (AR) and, consequently, standard therapies against prostate cancer involve androgen reduction through chemical or surgical castration [2, 3]. The gene discussed is AR; the disease is Familial prostate cancer.